433 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON Page of 9 | next »
Genei Gene descriptioni x Evidencei x Tissuei Braini Single celli Subcelli Canceri Bloodi Cell linei Struct & Inti Prognostic p-valuei x
ABHD14BAbhydrolase domain containing 14B
Kidney Renal Papillary Cell Carcinoma (TCGA): 7.41e-7
Glioblastoma Multiforme (validation): 5.89e-5
Pancreatic Adenocarcinoma (validation): 1.06e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 1.95e-4
ABLIM1Actin binding LIM protein 1
Kidney Renal Clear Cell Carcinoma (TCGA): 1.87e-7
Kidney Renal Clear Cell Carcinoma (validation): 2.47e-7
Pancreatic Adenocarcinoma (validation): 5.60e-4
ABRAXAS1Abraxas 1, BRCA1 A complex subunit
Kidney Renal Clear Cell Carcinoma (TCGA): 3.20e-7
Kidney Renal Clear Cell Carcinoma (validation): 1.81e-4
Liver Hepatocellular Carcinoma (TCGA): 2.22e-4
ACAP1ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
Head and Neck Squamous Cell Carcinoma (TCGA): 1.77e-5
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 3.18e-4
Lung Adenocarcinoma (TCGA): 7.51e-4
Breast Invasive Carcinoma (TCGA): 8.78e-4
ACTR3BActin related protein 3B
Liver Hepatocellular Carcinoma (validation): 3.22e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 3.28e-4
Liver Hepatocellular Carcinoma (TCGA): 5.13e-4
ADAM23ADAM metallopeptidase domain 23
ADAT2Adenosine deaminase tRNA specific 2
ADIRFAdipogenesis regulatory factor
Kidney Renal Clear Cell Carcinoma (TCGA): 2.48e-5
Kidney Renal Clear Cell Carcinoma (validation): 3.10e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.87e-4
Kidney Chromophobe (TCGA): 8.58e-4
ADORA2AAdenosine A2a receptor
Head and Neck Squamous Cell Carcinoma (TCGA): 3.95e-4
Pancreatic Adenocarcinoma (TCGA): 5.23e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 5.35e-4
ADPRMADP-ribose/CDP-alcohol diphosphatase, manganese dependent
Kidney Renal Clear Cell Carcinoma (TCGA): 6.85e-6
AFAP1L2Actin filament associated protein 1 like 2
Pancreatic Adenocarcinoma (TCGA): 1.51e-4
Ovary Serous Cystadenocarcinoma (validation): 2.20e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.47e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 6.83e-4
AGMATAgmatinase
Kidney Renal Clear Cell Carcinoma (TCGA): 3.00e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.09e-4
ALDOCAldolase, fructose-bisphosphate C
Glioblastoma Multiforme (validation): 2.98e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 3.36e-4
ANXA2RAnnexin A2 receptor
Colon Adenocarcinoma (validation): 2.64e-4
ANXA6Annexin A6
Pancreatic Adenocarcinoma (validation): 5.94e-4
APBA2Amyloid beta precursor protein binding family A member 2
Glioblastoma Multiforme (validation): 7.44e-4
APBA3Amyloid beta precursor protein binding family A member 3
Kidney Renal Clear Cell Carcinoma (TCGA): 2.34e-4
APPBP2Amyloid beta precursor protein binding protein 2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.23e-5
Liver Hepatocellular Carcinoma (TCGA): 7.00e-4
Bladder Urothelial Carcinoma (TCGA): 8.62e-4
ARHGAP45Rho GTPase activating protein 45
Head and Neck Squamous Cell Carcinoma (TCGA): 3.47e-4
ARHGEF35Rho guanine nucleotide exchange factor 35
Liver Hepatocellular Carcinoma (TCGA): 1.59e-4
ARHGEF5Rho guanine nucleotide exchange factor 5
ARRDC2Arrestin domain containing 2
Breast Invasive Carcinoma (validation): 1.48e-4
Ovary Serous Cystadenocarcinoma (TCGA): 1.63e-4
Glioblastoma Multiforme (TCGA): 7.12e-4
ASNSAsparagine synthetase (glutamine-hydrolyzing)
Kidney Renal Clear Cell Carcinoma (TCGA): 8.77e-8
Liver Hepatocellular Carcinoma (TCGA): 6.35e-6
Head and Neck Squamous Cell Carcinoma (TCGA): 6.39e-5
ATF2Activating transcription factor 2
Kidney Renal Clear Cell Carcinoma (TCGA): 8.81e-7
Liver Hepatocellular Carcinoma (TCGA): 3.31e-5
Kidney Chromophobe (TCGA): 3.80e-4
ATG14Autophagy related 14
Kidney Renal Clear Cell Carcinoma (TCGA): 4.67e-9
Colon Adenocarcinoma (validation): 1.09e-4
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 2.73e-4
Kidney Renal Clear Cell Carcinoma (validation): 6.98e-4
ATIC5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
Liver Hepatocellular Carcinoma (validation): 2.41e-10
Liver Hepatocellular Carcinoma (TCGA): 1.11e-8
Lung Adenocarcinoma (TCGA): 4.54e-4
ATL2Atlastin GTPase 2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.05e-5
Pancreatic Adenocarcinoma (TCGA): 2.61e-4
Rectum Adenocarcinoma (TCGA): 5.07e-4
Liver Hepatocellular Carcinoma (validation): 6.00e-4
ATP6V1E2ATPase H+ transporting V1 subunit E2
Liver Hepatocellular Carcinoma (TCGA): 5.51e-4
Kidney Chromophobe (TCGA): 8.73e-4
BAG2BAG cochaperone 2
Liver Hepatocellular Carcinoma (validation): 1.25e-6
Liver Hepatocellular Carcinoma (TCGA): 4.74e-6
Thyroid Carcinoma (TCGA): 4.65e-5
Skin Cuteneous Melanoma (TCGA): 5.18e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 5.38e-4
Lung Adenocarcinoma (TCGA): 8.72e-4
BCL2BCL2 apoptosis regulator
Kidney Renal Clear Cell Carcinoma (TCGA): 4.14e-11
Lung Adenocarcinoma (TCGA): 1.49e-4
Kidney Renal Clear Cell Carcinoma (validation): 6.27e-4
BCL9BCL9 transcription coactivator
Kidney Renal Clear Cell Carcinoma (TCGA): 2.59e-4
Liver Hepatocellular Carcinoma (TCGA): 7.18e-4
BEX2Brain expressed X-linked 2
Kidney Renal Clear Cell Carcinoma (TCGA): 6.13e-8
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.49e-7
BEX3Brain expressed X-linked 3
Kidney Renal Clear Cell Carcinoma (TCGA): 8.04e-5
Stomach Adenocarcinoma (TCGA): 1.93e-4
Uterine Corpus Endometrial Carcinoma (TCGA): 4.10e-4
BIN1Bridging integrator 1
Liver Hepatocellular Carcinoma (validation): 5.40e-5
Glioblastoma Multiforme (validation): 1.69e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.44e-4
Thyroid Carcinoma (TCGA): 4.47e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 5.71e-4
BIRC7Baculoviral IAP repeat containing 7
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 7.14e-4
BRD3OSBRD3 opposite strand
Kidney Renal Clear Cell Carcinoma (TCGA): 3.41e-8
C10orf95Chromosome 10 open reading frame 95
Kidney Renal Clear Cell Carcinoma (TCGA): 7.52e-4
C19orf73Chromosome 19 open reading frame 73
C1QTNF6C1q and TNF related 6
Lung Adenocarcinoma (TCGA): 1.54e-9
Kidney Renal Clear Cell Carcinoma (TCGA): 8.71e-8
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 2.00e-4
C3orf18Chromosome 3 open reading frame 18
Kidney Renal Papillary Cell Carcinoma (TCGA): 7.42e-5
Lung Adenocarcinoma (TCGA): 2.88e-4
Breast Invasive Carcinoma (validation): 7.46e-4
CA6Carbonic anhydrase 6
CARNS1Carnosine synthase 1
CBR3Carbonyl reductase 3
Pancreatic Adenocarcinoma (validation): 7.60e-4
CCDC141Coiled-coil domain containing 141
CCDC198Coiled-coil domain containing 198
Kidney Renal Clear Cell Carcinoma (TCGA): 1.51e-5
CCDC57Coiled-coil domain containing 57
Rectum Adenocarcinoma (validation): 7.52e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 6.43e-6
Pancreatic Adenocarcinoma (TCGA): 2.78e-4
CCDC59Coiled-coil domain containing 59
Liver Hepatocellular Carcinoma (validation): 4.15e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 7.44e-4
CCL28C-C motif chemokine ligand 28
Kidney Renal Clear Cell Carcinoma (TCGA): 1.01e-4
Pancreatic Adenocarcinoma (TCGA): 2.22e-4
Colon Adenocarcinoma (TCGA): 9.54e-4
CCR7C-C motif chemokine receptor 7
Head and Neck Squamous Cell Carcinoma (TCGA): 3.69e-6
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 1.36e-5
Lung Adenocarcinoma (TCGA): 5.44e-4
Page of 9 | next »